GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $74,000 | -47.1% | 1,721 | -46.6% | 0.00% | – |
| Q1 2022 | $140,000 | -89.8% | 3,221 | -89.6% | 0.00% | – |
| Q4 2021 | $1,368,000 | -53.1% | 31,036 | -59.3% | 0.00% | -100.0% |
| Q3 2021 | $2,916,000 | -93.9% | 76,331 | -93.7% | 0.00% | -95.7% |
| Q2 2021 | $47,954,000 | +2766.3% | 1,204,269 | +2467.1% | 0.02% | +2200.0% |
| Q1 2021 | $1,673,000 | -28.6% | 46,911 | -26.4% | 0.00% | 0.0% |
| Q4 2020 | $2,344,000 | +62.8% | 63,705 | +66.5% | 0.00% | – |
| Q3 2020 | $1,440,000 | -1.7% | 38,261 | +6.5% | 0.00% | – |
| Q2 2020 | $1,465,000 | -79.8% | 35,932 | -81.2% | 0.00% | -100.0% |
| Q1 2020 | $7,256,000 | -56.4% | 191,510 | -46.0% | 0.01% | -33.3% |
| Q4 2019 | $16,650,000 | +50.7% | 354,336 | +36.9% | 0.01% | +28.6% |
| Q3 2019 | $11,047,000 | -18.4% | 258,816 | -23.5% | 0.01% | -12.5% |
| Q2 2019 | $13,544,000 | +159.6% | 338,457 | +171.1% | 0.01% | +100.0% |
| Q1 2019 | $5,217,000 | -43.7% | 124,864 | -48.5% | 0.00% | -42.9% |
| Q4 2018 | $9,264,000 | -4.5% | 242,451 | +0.4% | 0.01% | 0.0% |
| Q3 2018 | $9,705,000 | -49.9% | 241,604 | -49.8% | 0.01% | -58.8% |
| Q2 2018 | $19,387,000 | +24.7% | 480,942 | +20.9% | 0.02% | +41.7% |
| Q1 2018 | $15,548,000 | +27.6% | 397,964 | +15.9% | 0.01% | +20.0% |
| Q4 2017 | $12,181,000 | -21.7% | 343,401 | -10.3% | 0.01% | -37.5% |
| Q3 2017 | $15,547,000 | +29.1% | 382,910 | +37.1% | 0.02% | +33.3% |
| Q2 2017 | $12,046,000 | +103.4% | 279,359 | +98.8% | 0.01% | +100.0% |
| Q1 2017 | $5,922,000 | -47.0% | 140,490 | -51.6% | 0.01% | -45.5% |
| Q4 2016 | $11,167,000 | +15.5% | 290,022 | +29.4% | 0.01% | 0.0% |
| Q3 2016 | $9,665,000 | -51.7% | 224,092 | -51.4% | 0.01% | -57.7% |
| Q2 2016 | $19,993,000 | +159.9% | 461,300 | +139.8% | 0.03% | +116.7% |
| Q1 2016 | $7,694,000 | -16.5% | 192,364 | -16.5% | 0.01% | 0.0% |
| Q4 2015 | $9,213,000 | -33.9% | 230,344 | -37.2% | 0.01% | -29.4% |
| Q3 2015 | $13,931,000 | -90.5% | 366,602 | -89.8% | 0.02% | -89.6% |
| Q2 2015 | $146,712,000 | -61.4% | 3,578,164 | -56.7% | 0.16% | -62.6% |
| Q1 2015 | $380,507,000 | +1370.2% | 8,271,967 | +1242.4% | 0.44% | +1652.0% |
| Q4 2014 | $25,882,000 | -11.6% | 616,210 | -5.2% | 0.02% | -10.7% |
| Q3 2014 | $29,274,000 | +113.1% | 650,304 | +151.1% | 0.03% | +86.7% |
| Q2 2014 | $13,735,000 | +16.6% | 258,955 | +16.5% | 0.02% | +7.1% |
| Q1 2014 | $11,783,000 | -16.1% | 222,280 | -16.1% | 0.01% | -6.7% |
| Q4 2013 | $14,047,000 | -3.3% | 265,044 | -8.7% | 0.02% | -11.8% |
| Q3 2013 | $14,520,000 | -43.3% | 290,398 | -43.3% | 0.02% | -48.5% |
| Q2 2013 | $25,590,000 | – | 512,120 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |